NVO
Novo Nordisk A/S
Novo Nordisk A/S historical holders
total: 8
Giverny Capital Novo Nordisk A/S transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Added:
- 1
- Held since:
- 2020 Q3
- Held for:
- 23 quarters
- Latest activity:
- 2023 Q3
Francois Rochon has been an institutional investor in Novo Nordisk A/S (NVO) since 2020 Q3. According to 2026 Q1 report, Francois Rochon holds 12,400 shares with a market value of roughly $455.70K representing 0.02% of their equity portfolio. The fund/company first acquired NVO in 2020 Q3, initially purchasing 6,200 shares. Since the initial investment, Giverny Capital has made 1 more transaction in this position.
Does Francois Rochon still hold NVO?
Yes, Francois Rochon continues to hold Novo Nordisk A/S (NVO). According to their 2026 Q1 report, they maintain a position of 12,400 shares valued at approximately $455.70K, representing 0.02% of their equity portfolio.
When did Francois Rochon first invest in NVO?
Francois Rochon first invested in Novo Nordisk A/S (NVO) in 2020 Q3 at the reported quarter-end price of $69.35 per share, acquiring 6,200 shares in their initial purchase.
What is Francois Rochon's average cost basis for NVO?
Based on historical transaction data, Francois Rochon's estimated cost basis for Novo Nordisk A/S (NVO) is approximately $80.15 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $80.15
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.